Exabis Library
Welcome to the e-CCO Library!
P355 Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P355: A structured care pathway improves quality of care for acute severe ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P355: Diagnostic accuracy and usability of home calprotectin testing
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P355: Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P355: Exceeding treatment expectations in Crohn's disease: transmural healing and a new definition of deep remission
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P355: Motility in small bowel strictures in Crohn's Disease measured with cine-MRI
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P355: Preferences and satisfaction of IBD patients in whom the adalimumab regimen was changed from 40 mg weekly to 80 mg every other week: the ADASCAL study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P355: Prevalence, clinical characteristics and outcomes of CMV colitis in a cohort of 95 patients with ulcerative colitis: A 7-year retrospective analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P356 Infectious events in patients with inflammatory bowel disease: The impact of immunomodulators and tumour necrosis factor antagonist therapy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P356: A comparison of innovative strategies to promote engagement with an IBD patient portal
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P356: CRAB Score, An Indian Insight into in hospital and long-term Colectomy following Acute Severe Ulcerative Colitis (ASUC)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P356: Czech experience with treatment of Crohn´s disease perianal fistulas by allogenic mesenchymal stem cell
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P356: Efficacy and safety of certolizumab pegol in Crohn’s disease patients with loss of response or intolerance to previous anti-TNF
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P356: Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in paediatric patients with inflammatory bowel disease: a multi-centre cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P356: The role of endoscopic activity in the coagulation profile of clinical remission Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P356: Treatment with anakinra induces T cell production of IL22 and GI mucosal healing in an IL-10RA mutation patient
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P357 Importance of stool drug monitoring in anti-TNF-treated patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P357: A multi-institutional report of postoperative outcomes in Vedolizumab-Treated patients undergoing major abdominal operations for inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P357: Do you think that complementary and alternative medicine use is frequent amongst inflammatory bowel disease patients: Forget it!—results from a comparative study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P357: Healthcare and medication utilisation in Singapore adult inflammatory bowel disease patients receiving immunomodulators and biologics
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM